Follow this link:
Vir Biotechnology Presents New Data on VIR-2482, the Company’s Investigational Monoclonal Antibody for the Prevention of Influenza A, at IDWeek 2020
Author Archives: Fredricko
electroCore, Inc. Appoints Business Development Leader and US Navy Veteran Sylvester Steele as VP and General Manager of Government Channels Business…
Trevi Therapeutics Provides Clinical Trial Updates for Haduvio™
Continue reading here:
Trevi Therapeutics Provides Clinical Trial Updates for Haduvio™
Neumentum and Nuance Biotech Enter into Licensing Agreement for NTM-001 (ketorolac for IV infusion) in China
Turning Point Therapeutics Announces Abstract For TRIDENT-1 Clinical Study of Repotrectinib Accepted For Presentation at World Conference on Lung…
AzurRx BioPharma Announces Formation of Scientific Advisory Board
Cidara Therapeutics Announces New Clinical and Preclinical Data for Rezafungin and Influenza AVCs at IDWeek 2020
Paratek Pharmaceuticals Presenting New Data on NUZYRA® (Omadacycline) at IDWeek 2020
Teneobio Announces a Research Collaboration and License Agreement With ArsenalBio
Immutep Granted European Patent for IMP761
Original post:
Immutep Granted European Patent for IMP761
Greenwich Biosciences, Inc., a Subsidiary of GW Pharmaceuticals plc, Launches unspoken symphony, a Breakthrough Innovation Created for the US Epilepsy…
Radius Health, Inc.: Progress Since May 2020
Original post:
Radius Health, Inc.: Progress Since May 2020
Myovant Sciences Presents Additional Data on Relugolix Combination Therapy from Studies in Endometriosis and Uterine Fibroids
SCYNEXIS to Present Data Supporting the Efficacy of Ibrexafungerp Against Invasive Fungal Infections at IDWeek 2020
The Quest for Blockbuster Drugs Continues
Continued here:
The Quest for Blockbuster Drugs Continues
Artelo Biosciences Files Patent on Use of Fatty Acid Binding Protein 5 Inhibitors for Treating Psychological Disorders
Telo Genomics Announces Warrant Exercise Agreement
See original here:
Telo Genomics Announces Warrant Exercise Agreement
Zosano Pharma Receives Complete Response Letter from FDA for Qtrypta™
See the rest here:
Zosano Pharma Receives Complete Response Letter from FDA for Qtrypta™
Caladrius Biosciences to Participate in the 8th Annual Chief Medical Officer Summit 360°
Novan to Present at the Virtual Investor KOL Roundtable
Go here to see the original:
Novan to Present at the Virtual Investor KOL Roundtable